GGrantIndex
← Leaderboards

Elizabeth A Stewart

Brigham And Women'S Hospital

$4,734,535
Attributed
$6,104,994
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,207,675 · 6

By mechanism

R01$4,437,823 · 2
P50$3,631,561 · 2
RC1$974,131 · 1
K08$164,160 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Uterine Fibroids

Research focus

Uterine FibroidsFibroid TumorWomanHysterectomyHemorrhagePainSymptomsUterine MyomectomyClinicSymptomatic ImprovementReportingCohortUniversitiesOperative Surgical ProceduresImpairmentSuccessQuality Of LifePregnancyMenopauseMorbidity - Disease RatePressureCaringBlack RaceLocation

Grant awards (16)

COllaboration for EQuity in Uterine Leiomyomas$1,516,960
P50 · FY2025 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$600,362
R01 · FY2025 · HD
Supporting COEQUal projects and personnel: Administrative CORE$230,936
P50 · FY2025 · HD · contact PI
COllaboration for EQuity in Uterine Leiomyomas$1,585,721
P50 · FY2024 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$592,123
R01 · FY2024 · HD
Supporting COEQUal projects and personnel: Administrative CORE$297,944
P50 · FY2024 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$634,794
R01 · FY2023 · HD
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$593,545
R01 · FY2014 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$538,400
R01 · FY2013 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$580,969
R01 · FY2012 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$581,372
R01 · FY2011 · HD · contact PI
Comparing focused ultrasound and uterine artery embolization for uterine fibroids$474,021
RC1 · FY2010 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$316,258
R01 · FY2010 · HD · contact PI
Comparing focused ultrasound and uterine artery embolization for uterine fibroids$500,110
RC1 · FY2009 · HD · contact PI
MOLECULAR ENDOCRINOLOGY OF THE UTERUS$82,080
K08 · FY2001 · HD
MOLECULAR ENDOCRINOLOGY OF THE UTERUS$82,080
K08 · FY2000 · HD